Rheumatoid Arthritis Clinical Trials in Phoenix

Showing 1061-1080 of 3,170 trials

Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease

NCT01731990

This study was designed to assess the safety, tolerability and efficacy of ACZ885 on the leg artery structure and physical activity in patients with atherosclerotic peripheral artery disease and leg pain from walking.

Peripheral Artery Disease

Novartis Pharmaceuticals38 participantsStarted Oct 2012

Phoenix, Arizona, United States • Jacksonville, Florida, United States • Jacksonville, Florida, United States +11 more locations

Active Not RecruitingPhase 2< 1 mile

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

NCT04239625

The purpose of this open-label, multicenter study is to determine the long-term safety, pharmacokinetics and effects of ALK-001 (C20-D3-retinyl acetate) on the progression of Stargardt disease. This study is an extension of NCT02402660 and enrolls participants who are at least 8 years old. Enrollment is by invitation only. Funding Source - FDA OOPD

Stargardt DiseaseStargardt Macular DegenerationStargardt Macular Dystrophy+1 more

Alkeus Pharmaceuticals, Inc.200 participantsStarted Dec 2019

Phoenix, Arizona, United States • Los Angeles, California, United States • Aurora, Colorado, United States +5 more locations

Safety, Tolerability and Efficacy of ACZ885 on Leg Artery Structure in Patients With Peripheral Artery Disease

Open-Label Extension: Tolerability and Effects of ALK-001 on Stargardt Disease (TEASE)

Rheumatoid Arthritis Trials in Other Cities

DALY II USA/ MB-CART2019.1 for DLBCL

Laser Ablation of Abnormal Neurological Tissue Using Robotic NeuroBlate System

Comparative Study of Conventional MR Images With Synthetically Reconstructed MR Images of the Brain

A Study of CTX-009 in Combination With Paclitaxel in Adult Patients With Unresectable Advanced, Metastatic or Recurrent Biliary Tract Cancers (COMPANION-002)

Study to Evaluate the Efficacy and Safety of Intravitreal OTX-TKI (Ocular Therapeutix) (Axitinib Implant) in Subjects With Neovascular Age-Related Macular Degeneration

Phase 2b Study of MBS2320 in Participants With Methotrexate-Refractory RA

Massed Prolonged Exposure for PTSD in Substance Use Treatment

A Study to Evaluate Rozanolixizumab in Study Participants With Generalized Myasthenia Gravis

A Study to Evaluate the Safety and Efficacy of Ustekinumab Induction and Maintenance Therapy in Participants With Moderately to Severely Active Ulcerative Colitis

Study of REM-422 in Patients With AML or Higher Risk MDS

A Study to Investigate BGB-3245 (Brimarafenib) With Panitumumab in Participants With Advanced or Metastatic RAS Mutant Colorectal and Pancreatic Ductal Cancers

MERIDIAN: A Study to Evaluate the Efficacy and Safety of Pegcetacoplan in Adults With Amyotrophic Lateral Sclerosis (ALS)

Clinical Trial Readiness to Solve Barriers to Drug Development in FSHD

User Acceptability Evaluation of Pseudophakic Patients Previously Implanted With the TECNIS Odyssey IOL

IDP-023 g-NK Cells Plus Ocrelizumab in Patients With Progressive Multiple Sclerosis

A Phase 1/2, First-in-Human Dose Escalation/Expansion Study to Evaluate the Safety, Tolerability and Preliminary Efficacy of a Subretinal Injection of SB-007 in Subjects With Stargardt Disease (STGD1)

Telehealth Delivered Home-based Walking for Vets With Peripheral Artery Disease

Phase 2 Study of HL-009 Liposomal Gel to Treat Mild to Moderate Atopic Dermatitis

Other Conditions in Phoenix